Bessemer Group’s Q32 Bio QTTB Stock Holding History

Bessemer Group’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,156	Closed	-$1.14M	–	1702
2020 Q2	$1.14M	Buy	+4,156	New	+$1.11M	﹤0.01%	725

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bessemer Group's QTTB Position: Q3 2020 in Review

Bessemer Group sold out of Q32 Bio (QTTB) in Q3 2020, closing a stake of 4,156 shares — an estimated $1.14M sold.

Bessemer Group first reported a position in QTTB in Q2 2020 and held it in 1 quarter. The position peaked at $1.14M in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q3 2020.

Bessemer Group reported no remaining Q32 Bio position as of Q3 2020 after selling out during the quarter.
Bessemer Group sold 4,156 Q32 Bio shares in Q3 2020, an estimated $1.14M.
Bessemer Group first reported a position in Q32 Bio in Q2 2020 and held it in 1 quarter.
Bessemer Group's Q32 Bio position peaked at $1.14M in Q2 2020.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.